Skip Nav Destination
Issues
1 February 2025
-
Cover Image
Cover Image
The cover image is adapted from Fig. 1 in the article, “Socioeconomic Inequalities in Participation in Colorectal Cancer Screening in Ontario, Canada: A Decomposition Analysis,” by Jalili and colleagues. The relationship between socioeconomic status and colorectal cancer screening in Canada remains poorly understood. This study aims to measure and explain the extent of socioeconomic inequalities in colorectal cancer screening participation in Ontario, Canada and used cross-sectional data from the Public Use Microdata Files of the Canadian Community Health Survey conducted in 2017 to 2018, which is the latest available cycle for public use. Figure 1 illustrates the absolute contribution of each factor to the observed income related inequalities in colorectal cancer screening participation. The figure highlights that income, education, and language of communication are the three primary contributors to pro-rich inequality in colorectal cancer screening in Ontario, Canada. The results suggested that colorectal cancer screening uptake rates varied across other different sociodemographic and socioeconomic groups. Factors such as age, race, immigration status, marital status, income, education level, and employment status showed significant associations with colorectal cancer screening participation. Income is the primary driver of socioeconomic inequality, requiring targeted strategies to boost screening rates among low-income residents. Addressing education and language barriers through awareness initiatives and language support can reduce socioeconomic inequalities in cancer screening uptake in Ontario. For more information, see the article beginning on page 270. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
In the Spotlight
Research Articles
Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Xiaosong Huang; Paul C. Lott; Donglei Hu; Valentina A. Zavala; Zoeb N. Jamal; Tatiana Vidaurre; Sandro Casavilca-Zambrano; Jeannie Navarro Vásquez; Carlos A. Castañeda; Guillermo Valencia; Zaida Morante; Mónica Calderón; Julio E. Abugattas; Hugo A. Fuentes; Ruddy Liendo-Picoaga; Jose M. Cotrina; Silvia P. Neciosup; Patricia Rioja Viera; Luis A. Salinas; Marco Galvez-Nino; Scott Huntsman; Sixto E. Sanchez; Michelle A. Williams; Bizu Gelaye; Ana P. Estrada-Florez; Guadalupe Polanco-Echeverry; Magdalena Echeverry; Alejandro Velez; Jenny A. Carmona-Valencia; Mabel E. Bohorquez-Lozano; Javier Torres; Miguel Cruz; Weang-Kee Ho; Soo Hwang Teo; Mei Chee Tai; Esther M. John; Christopher A. Haiman; David V. Conti; Fei Chen; Gabriela Torres-Mejía; Lawrence H. Kushi; Susan L. Neuhausen; Elad Ziv; Luis G. Carvajal-Carmona; for the COLUMBUS Consortium; Laura Fejerman
Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years
Jessica Chubak; Laura E. Ichikawa; Sophie A. Merchant; Ronit R. Dalmat; Rebecca A. Ziebell; Christopher D. Jensen; Jeffrey K. Lee; Douglas A. Corley; Nirupa R. Ghai; Beverly B. Green; Celette Sugg Skinner; Joanne E. Schottinger; Erica S. Breslau; Theodore R. Levin
Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019
Connor R. Miller; Liane M. Schneller-Najm; Noel J. Leigh; Thomas Agar; Anne CK. Quah; K. Michael Cummings; Geoffrey T. Fong; Richard J. O’Connor; Maciej L. Goniewicz
The Influence of Residential Segregation, Urbanicity, and Population Density on Hepatocellular Carcinoma Incidence among a Low Socioeconomic Population
Corianne R. Johnson; Sylvie Muhimpundu; Xijing Han; Michael T. Mumma; Martha J. Shrubsole; Wei Zheng; Lucy B. Spalluto; Loren Lipworth; Staci L. Sudenga
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.